EUVIMEDOpdag EUVIMED
Crossref

Retrospective evaluation of the short‐term response of human intravenous immunoglobulin therapy in the management of canine immune‐mediated thrombocytopenia (2010–2015): 27 cases

Andrea Zoia iD, Francesca Busato, Michele Drigo

Journal of Veterinary Emergency and Critical Care · 2024

DOI: 10.1111/vec.13408 ↗

At a glance

Journal article in Journal of Veterinary Emergency and Critical Care, 2024. Written by Andrea Zoia and 2 co-authors. Institution: Division of Internal Medicine, San Marco Veterinary Clinic, Veggiano, Italy. Major MEDLINE topics: Dog Diseases, Immunoglobulins, Intravenous, Purpura, Thrombocytopenic, Idiopathic. Cited 1 times so far (Crossref); 63 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

To describe the short‐term response, early prognostic markers, and survival after treatment of canine immune‐mediated thrombocytopenia (ITP) with human intravenous immunoglobulin (hIVIG) and methylprednisolone.

Design

Retrospective cohort study. Settings Private referral veterinary medical center. Animals Twenty‐seven client‐owned dogs with primary or secondary ITP.

Interventions

All dogs received 2 mg/kg IV methylprednisolone once daily and a single infusion of 5% hIVIG administered over 6–12 hours. Measurements and Main Results A substantial increase in platelet count within 60 ± 12 hours post‐hIVIG infusion (T 60 ) was observed in 19 of the 27 (70%) dogs with ITP (responders). Thirty‐four variables, including serum immunoglobulin (Ig) G concentration 24 ± 12 hours post‐hIVIG infusion (T 24 IgG) and increase in serum IgG concentration 24 ± 12 hours post‐hIVIG infusion (T 24 Δ IgG ), were compared between responders and nonresponders at 5 different time points. Mortality rates of responders and nonresponders were evaluated 14 days post‐hIVIG infusion. Serum T 24 IgG and serum T 24 Δ IgG were both significantly higher at T 60 in responders. All responders were alive 14 days post‐hIVIG infusion, and their mortality rate was significantly lower compared with nonresponders.

Conclusions

Responder dogs had an excellent 14‐day survival rate. Serum T 24 IgG and serum T 24 Δ IgG concentrations accurately predicted response status at 60 hours post‐hIVIG infusion.

Subjects

MeSH terms (MEDLINE)

Dog DiseasesImmunoglobulins, IntravenousPurpura, Thrombocytopenic, IdiopathicDogsAnimalsRetrospective StudiesFemaleMaleHumansMethylprednisoloneCohort StudiesTreatment Outcome

Author keywords

ITPcanineglucocorticoidshIVIG

Substances

Immunoglobulins, IntravenousMethylprednisolone

Authors and institutions

  • Division of Internal Medicine, San Marco Veterinary Clinic, Veggiano, Italy.
  • Department of Medicina Animale, Produzione e Salute, Padua University, Legnaro, Italy.

ORCID profiles: Andrea Zoia

Cite

APA

Zoia, A., Busato, F., & Drigo, M. (2024). Retrospective evaluation of the short‐term response of human intravenous immunoglobulin therapy in the management of canine immune‐mediated thrombocytopenia (2010–2015): 27 cases. Journal of Veterinary Emergency and Critical Care. https://doi.org/10.1111/vec.13408

Vancouver

Zoia A, Busato F, Drigo M. Retrospective evaluation of the short‐term response of human intravenous immunoglobulin therapy in the management of canine immune‐mediated thrombocytopenia (2010–2015): 27 cases. Journal of Veterinary Emergency and Critical Care. 2024. doi:10.1111/vec.13408

BibTeX
@article{Zoia2024,
  author = {Zoia, Andrea and Busato, Francesca and Drigo, Michele},
  title = {Retrospective evaluation of the short‐term response of human intravenous immunoglobulin therapy in the management of canine immune‐mediated thrombocytopenia (2010–2015): 27 cases},
  journal = {Journal of Veterinary Emergency and Critical Care},
  year = {2024},
  doi = {10.1111/vec.13408}
}
Start for free →